Articles dans des revues avec comité de lecture (7)
  1. 1. Hubesch, G., Dewachter, C., Chomette, L., Hupkens, E., Jespers, P., Vegh, G., Doppler, M., Sheikh Mohammad, U., Thiriard, A., Remmelink, M., Vachiery, J.-L., McEntee, K., & Dewachter, L. (2024). Early Alteration of Right Ventricle-Pulmonary Artery Coupling in Experimental Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association, 13(11), e032201. doi:10.1161/JAHA.123.032201
  2. 2. El Oumeiri, B. G., Dewachter, L., Van De Borne, P., Hubesch, G., Melot, C., Jespers, P., Stefanidis, C., McEntee, K., & Vanden Eynden, F. (2023). Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil. Genes, 14(1). doi:10.3390/genes14010122
  3. 3. El Oumeiri, B. G., Van De Borne, P., Hubesch, G., Jespers, P., Dewachter, L., Stefanidis, C., McEntee, K., & Vanden Eynden, F. (2022). Detection of soluble suppression of tumorigenicity 2 and N-terminal B-type natriuretic peptide in a rat model of aortic regurgitation: differential responses to omecamtiv mecarbil. Journal of basic & clinical physiology & pharmacology, 33(6), 743-750. doi:10.1515/jbcpp-2022-0215
  4. 4. Garcia, B., Su, F., Dewachter, L., Favory, R., Khaldi, A., Moiroux-Sahraoui, A., Annoni, F., Vasques-Nóvoa, F., Rocha-Oliveira, E., Roncon-Albuquerque, R., Hubesch, G., Njimi, H., Vincent, J. L., Taccone, F. S., Creteur, J., & Herpain, A. (2022). Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock. Critical care, 26(1), 281. doi:10.1186/s13054-022-04161-3
  5. 5. Hubesch, G., Hanthazi, A., Acheampong, A., Chomette, L., Lasolle, H., Hupkens, E., Jespers, P., Vegh, G., Watu Malu Wembonyama, C., Verhoeven, C., Dewachter, C., Vachiery, J.-L., McEntee, K., & Dewachter, L. (2022). A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities. Frontiers in Cardiovascular Medicine, 8. doi:10.3389/fcvm.2021.809885
  6. 6. El Oumeiri, B. G., Van De Borne, P., Hubesch, G., Herpain, A., Annoni, F., Jespers, P., Stefanidis, C., Mc Entee, K., & Vanden Eynden, F. (2021). The myosin activator omecamtiv mecarbil improves wall stress in a rat model of chronic aortic regurgitation. Physiological Reports, 9(16), e14988. doi:10.14814/phy2.14988
  7. 7. Hanthazi, A., Jespers, P., Vegh, G., Dubois, C., Hubesch, G., Springael, J.-Y., Dewachter, L., & McEntee, K. (2020). Chemerin Added to Endothelin-1 Promotes Rat Pulmonary Artery Smooth Muscle Cell Proliferation and Migration. Frontiers in physiology, 11, 926. doi:10.3389/fphys.2020.00926
    8.   Participations à des congrès et colloques internationaux (14)
  8. 1. Sheikh Mohammad, U., Hubesch, G., Vegh, G., Van Nuffelen, C., Tordeur, C., Singh, S. P., McEntee, K., Vachiery, J.-L., Rorive, S., Dewachter, C., & Dewachter, L. (2026). Progressive Renal Remodeling and Glucose Transporter Dysregulation in an Experimental Model of HFpEF associated with Metabolic Syndrome. Poster présenté à la conférence Belgium Society of cardiology (45th: 29-30 January 2026: Brussels, Belgium).
  9. 2. Sheikh Mohammad, U., Hubesch, G., Vegh, G., Hupkens, E., Jespers, P., Van Nuffelen, C., Tordeur, C., Singh, S. P., McEntee, K., Vachiery, J.-L., Rorive, S., Dewachter, C., & Dewachter, L. (2025). Characterization of renal alterations in an experimental model of HFpEF associated with metabolic syndrome in rats. Poster présenté à la conférence Printemps de la cardiologie (21 au 23 mai 2025: Palais du Grand Large à Saint-Malo).
  10. 3. Sheikh Mohammad, U., Hubesch, G., Van Eycken, M., Vegh, G., Hupkens, E., Jespers, P., Singh, S. P., McEntee, K., Vachiery, J.-L., Rorive, S., Dewachter, C., & Dewachter, L. (2024). Early renal alterations in metabolic syndrome-associated heart failure with preserved ejection fraction (HFpEF) in rats. Abstract session presented at BRC Belgian Working Group on Basic Research in Cardiology(9-12-2024: Auditorium Léon Frédéricq – GIGA Research Insitute University of Liège (Campus Sart-Tilman))
  11. 4. Sheikh Mohammad, U., Hubesch, G., Van Eycken, M., Vegh, G., Hupkens, E., Jespers, P., Singh, S. P., McEntee, K., Rorive, S., Dewachter, C., & Dewachter, L. (2024). Early renal alterations in an experimental model of heart failure with preserved ejection fraction (HFpEF) associated to metabolic syndrome. Abstract session presented at FNRS Metabolism Contact Group 2024(25-10-2024: Faculté de Medecine, ULB)
  12. 5. Sheikh Mohammad, U., Hubesch, G., Van Eycken, M., Vegh, G., Hupkens, E., Jespers, P., Singh, S. P., McEntee, K., Vachiery, J.-L., Rorive, S., Dewachter, C., & Dewachter, L. (2024). Which organ fails first in an experimental model of group 2 PH associated to HFpEF? Abstract session presented at The RHU DESTINATION 2024 project hosts the Thalys meeting(2/10/2024: Faculté de Médecine - University of Paris-Saclay Porte 16 - Bâtiment de recherche 63 Rue Gabriel Péri 94270 Le Kremlin-Bicêtre, France)
    13. << Précédent 1 2 Suivant >>